Perfusion imaging sales will strengthen through 2036, anchored by magnetic resonance imaging at a 27.6% share in 2026 as the leading modality type segment. The market was valued at USD 2.50 billion in 2025 and is expected to reach USD 3.25 billion by 2036, creating an incremental opportunity of USD 0.69 billion.